X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9887) 9887
Publication (787) 787
Newsletter (572) 572
Book Review (182) 182
Book Chapter (62) 62
Magazine Article (61) 61
Newspaper Article (61) 61
Transcript (18) 18
Conference Proceeding (15) 15
Dissertation (14) 14
Trade Publication Article (7) 7
Book / eBook (3) 3
Data Set (3) 3
Paper (2) 2
Presentation (2) 2
Reference (2) 2
Web Resource (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
warfarin (7425) 7425
humans (6862) 6862
index medicus (4472) 4472
male (3413) 3413
female (3068) 3068
anticoagulants (2709) 2709
aged (2519) 2519
pharmacology & pharmacy (2299) 2299
middle aged (2243) 2243
anticoagulants - therapeutic use (2186) 2186
drug interactions (2164) 2164
atrial fibrillation (1973) 1973
warfarin - therapeutic use (1772) 1772
anticoagulants - adverse effects (1726) 1726
anticoagulants - administration & dosage (1704) 1704
stroke (1679) 1679
warfarin - adverse effects (1474) 1474
adult (1419) 1419
warfarin - administration & dosage (1415) 1415
risk factors (1334) 1334
international normalized ratio (1285) 1285
dabigatran (1210) 1210
anticoagulation (1207) 1207
administration, oral (1183) 1183
atrial fibrillation - drug therapy (1168) 1168
prevention (1160) 1160
cardiac & cardiovascular systems (1145) 1145
therapy (1130) 1130
aged, 80 and over (1120) 1120
hematology (1077) 1077
analysis (1051) 1051
thromboembolism (978) 978
risk (971) 971
research (944) 944
stroke - prevention & control (944) 944
atrial-fibrillation (928) 928
rivaroxaban (927) 927
hemorrhage - chemically induced (924) 924
peripheral vascular disease (914) 914
medicine, general & internal (901) 901
drug therapy (870) 870
warfarin - pharmacology (857) 857
treatment outcome (848) 848
care and treatment (841) 841
medicine & public health (820) 820
pharmacokinetics (809) 809
atrial fibrillation - complications (791) 791
management (766) 766
animals (762) 762
dosage and administration (713) 713
venous thromboembolism (684) 684
retrospective studies (651) 651
apixaban (634) 634
aspirin (634) 634
stroke prevention (625) 625
cardiac arrhythmia (624) 624
anticoagulants - pharmacology (621) 621
patients (618) 618
thrombosis (610) 610
bleeding (606) 606
health aspects (605) 605
warfarin - pharmacokinetics (591) 591
dose-response relationship, drug (577) 577
drugs (565) 565
cardiology (564) 564
abridged index medicus (559) 559
internal medicine (555) 555
anticoagulants - pharmacokinetics (546) 546
antithrombotic therapy (531) 531
stroke - etiology (527) 527
prothrombin time (524) 524
hemorrhage (517) 517
pharmacogenetics (515) 515
blood coagulation - drug effects (511) 511
mortality (504) 504
time factors (493) 493
thrombin (491) 491
safety (489) 489
medical research (486) 486
oral anticoagulants (485) 485
drug-interactions (480) 480
metabolism (480) 480
warfarin - metabolism (473) 473
cyp2c9 (470) 470
complications and side effects (466) 466
pharmacology (440) 440
usage (439) 439
medicine, experimental (425) 425
clinical trials (417) 417
protein binding (416) 416
vitamin k - antagonists & inhibitors (412) 412
thromboembolism - prevention & control (406) 406
genotype (400) 400
pharmacology/toxicology (384) 384
warfarin - blood (378) 378
risk assessment (377) 377
cytochrome p-450 cyp2c9 (375) 375
medicine (374) 374
fibrillation (368) 368
risk-factors (368) 368
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10411) 10411
Japanese (58) 58
French (42) 42
German (34) 34
Spanish (22) 22
Norwegian (15) 15
Chinese (14) 14
Czech (10) 10
Korean (10) 10
Russian (10) 10
Swedish (10) 10
Danish (6) 6
Italian (4) 4
Dutch (3) 3
Turkish (3) 3
Croatian (2) 2
Hungarian (2) 2
Polish (2) 2
Portuguese (2) 2
Arabic (1) 1
Finnish (1) 1
Hebrew (1) 1
Romanian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Trends in Pharmacological Sciences, ISSN 0165-6147, 2013, Volume 34, Issue 3, pp. 178 - 184
Drug–drug interactions (DDIs) are an emerging threat to public health. Recent estimates indicate that DDIs cause nearly 74 000 emergency room visits and 195... 
Advanced Basic Science | IN-VITRO | ADVERSE-EVENT REPORTS | COLCHICINE | THERAPY | DATABASE | WARFARIN | PHARMACOLOGY & PHARMACY | SIMVASTATIN | ASSOCIATION | HOSPITALIZATION | PREDICTION | Informatics | Humans | Drug Interactions | Drug interactions
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 02/2011, Volume 66, Issue 2, pp. 235 - 239
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue 21, pp. 2230 - 2239
Oral anticoagulants are commonly prescribed but high risk to cause adverse events. Skilled drug interaction management is essential to ensure safe and... 
SEROTONIN REUPTAKE INHIBITORS | WARFARIN ANTICOAGULATION | DABIGATRAN ETEXILATE | VENOUS THROMBOEMBOLISM | INTRACEREBRAL HEMORRHAGE | PROTHROMBIN TIME | ATRIAL-FIBRILLATION INSIGHTS | DIRECT ORAL ANTICOAGULANTS | NATIONWIDE COHORT | HEMATOLOGY | ANTIPLATELET THERAPY
Journal Article
AMERICAN FAMILY PHYSICIAN, ISSN 0002-838X, 05/2019, Volume 99, Issue 9, pp. 558 - 564
Drug interactions are common in the primary care setting and are usually predictable. Identifying the most important and clinically relevant drug interactions... 
MEDICINE, GENERAL & INTERNAL | WARFARIN | LIFE-THREATENING HYPERKALEMIA | ORAL ANTICOAGULANTS | SPIRONOLACTONE | PRAVASTATIN | PHARMACODYNAMICS | PRIMARY HEALTH CARE | SIMVASTATIN | RHABDOMYOLYSIS | COMBINED THERAPY | BIOAVAILABILITY
Journal Article
Annals of Oncology, ISSN 0923-7534, 12/2009, Volume 20, Issue 12, pp. 1907 - 1912
Background: Drug-drug interactions (DDIs) comprise an important problem in medical oncology practice. We systematically reviewed the frequency of DDIs in... 
Adverse effects | Drug therapy | Drug interactions | Neoplasms | PALLIATIVE CARE | drug interactions | drug therapy | RISK | CHEMOTHERAPY | CANCER-PATIENTS | PHENYTOIN | POTENTIATION | ONCOLOGY | WARFARIN | adverse effects | IRINOTECAN | PRESCRIPTIONS | neoplasms | Medical Oncology | Antineoplastic Agents - therapeutic use | Drug Interactions | Antineoplastic Agents - adverse effects | Humans
Journal Article
Archives of Pharmacal Research, ISSN 0253-6269, 11/2011, Volume 34, Issue 11, pp. 1829 - 1842
As the use of herbal medicines increases, the public health consequences of drug-herb interactions are becoming more significant. Herbal medicines share the... 
UDP-glucuronosyltransferases | In vitro methods | Cytochrome P450 | Herb-drug interactions | HYPERICUM-PERFORATUM | CHEMISTRY, MEDICINAL | GINKGO-BILOBA EXTRACT | IN-VITRO METABOLISM | HUMAN LIVER-MICROSOMES | TANDEM MASS-SPECTROMETRY | MECHANISM-BASED INACTIVATION | UDP-GLUCURONOSYLTRANSFERASE ENZYMES | HUMAN HEPATOCYTES | PHARMACOLOGY & PHARMACY | ST-JOHNS-WORT | HUMAN CYTOCHROME-P450 ENZYMES | Intestines - drug effects | Liver - enzymology | Cytochrome P-450 Enzyme Inhibitors | Humans | Cytochrome P-450 Enzyme System - metabolism | Biological Availability | Intestines - metabolism | Glucuronosyltransferase - genetics | Enzyme Inhibitors - pharmacokinetics | Liver - drug effects | Plant Preparations - pharmacology | Plant Preparations - pharmacokinetics | Enzyme Induction - drug effects | Biological Transport - drug effects | Plant Preparations - adverse effects | Enzyme Inhibitors - adverse effects | Recombinant Proteins - metabolism | Drug Evaluation, Preclinical - methods | Recombinant Proteins - antagonists & inhibitors | Liver - metabolism | Enzyme Inhibitors - pharmacology | Animals | Glucuronosyltransferase - metabolism | Biotransformation - drug effects | Herb-Drug Interactions | Cytochrome P-450 Enzyme System - genetics | Glucuronosyltransferase - antagonists & inhibitors | Pharmacokinetics | Intestines - enzymology | Enzymes | Warfarin | Digoxin | Drug interactions | Cyclosporine | Nifedipine | Alprazolam | Tacrolimus | Medicine, Botanic | Analysis | Physiological aspects | Medicine, Herbal | Public health
Journal Article
Annual Review of Pharmacology and Toxicology, ISSN 0362-1642, 1/2019, Volume 59, Issue 1, pp. 507 - 536
Journal Article
Journal Article